AstraZeneca: AstraZeneca's New Asthma Treatment Shows Strong Results In Late-stage Trials

(RTTNews) - AstraZeneca Plc.'s (AZN.L, AZN) triple-combination inhaler, Breztri Aerosphere, has shown positive results in late-stage clinical trials for patients with uncontrolled asthma. The trials, called KALOS and LOGOS, found that the inhaler significantly improved lung funct